A Phase IV Non-Interventional Enhanced Active Surveillance Study of Adults Vaccinated with AZD1222

31/05/2021
23/04/2024
EU PAS number:
EUPAS41335
Study
Finalised
Subscribe
Download as PDF
Documents
Study protocol
Initial protocol

D8111R00003-PASS-Protocol Final to Client 22 Apr 2021 - Redacted

English (845.77 KB - PDF) View document
Updated protocol

D8111r00003-PASS-Protocol V2 Final to Client 26 May 2021_Redacted

First published: 22/02/2024
English (3.17 MB - PDF) View document
Study results
Study results

D8111R00003 EUPAS41335 clinical-study-report Final 20 Apr 2022_Redacted

English (1.81 MB - PDF) View document
Study report
Study report

d8111r00003-eu-pass-ia2-report_sponsor review_final redacted_17-JAN-2022

English (4.54 MB - PDF) View document

D8111R00003-report-1st-ia Final to Client 01 Oct 2021_Redacted

English (728.46 KB - PDF) View document
Other information
Study, other information

D8111R00003-report-1st-ia Final to Client 01 Oct 2021_Redacted.pdf

English (728.46 KB - PDF) View document